Search for Wyeth Corp and
    1. January 5, 2014

      Former SAC manager resolute as trial poised to start

      When prosecutors open their trial this week against Mathew Martoma, a former SAC Capital portfolio manager accused of...

    2. July 30, 2013

      Pfizer finalises overselling settlement

      Pfizer has finalised a criminal and civil settlement worth $491m with US authorities for alleged overselling of a transplant...

    1. July 5, 2013

      Scandals fuel view that foreign formula is safer

      For Wang Ya, a pigtailed 25-year-old mother pushing a pram through a Beijing supermarket, buying infant formula for her...

    2. July 3, 2013

      Baby milk makers slash prices in bow to Beijing regulators

      Baby milk manufacturers including Nestlé are to slash prices in China by up to 20 per cent to address regulators’ concerns...

    3. March 15, 2013

      SAC in record $614m insider settlements

      SAC Capital, the $15bn hedge fund run by Steven Cohen, paid $614m to settle civil insider trading charges, in what...

    4. February 13, 2013

      US authorities widen SAC Capital probe

      US authorities are expanding their investigation into potential insider trading involving SAC Capital , the $14bn hedge...

    5. FT Alphaville

      February 4, 2013

      Why do CFDs baffle the cops?

      The question is rhetorical. Back in December we were able to share a long, angry letter penned by Vincent Tchenguiz...

    6. January 3, 2013

      Ex-SAC official denies insider trading claims

      Mathew Martoma, a former portfolio manager with a unit of the hedge fund SAC Capital, has pleaded not guilty to allegations...

    7. November 27, 2012

      SAC chiefs to address investors’ concerns

      SAC Capital will hold a conference call with its investors Wednesday to address concerns about the hedge fund’s links to...

    8. November 23, 2012

      Doctors tread warily over insider trading

      When Yves Benhamou, a French doctor, took a flight to Boston two years ago, he ended up with a longer and less pleasant stay...

    9. November 20, 2012

      Cohen linked to $276m insider trading scheme

      US officials have linked Steven Cohen, founder of SAC Capital, one of Wall Street’s most powerful hedge funds, to an...

    10. October 12, 2012

      Reckitt keeps its gleam on acquisition talk

      Reckitt Benckiser held steady in a falling London market on Friday amid talk of potential acquisitions. The maker of Cillit...

    11. September 11, 2012

      Pfizer moves supply chain to cloud

      Over the past 18 months, Pfizer, the global pharmaceuticals giant, has completely re-engineered its complex supply chain,...

    12. June 28, 2012

      FDA clears first obesity drug in 10 years

      The US Food and Drug Administration has approved the first anti-obesity drug in more than a decade in a move that signals...

    13. May 1, 2012

      Pfizer

      A sobering exercise for any exuberant investor: take your favourite company and consider what would happen if its most...

    14. April 23, 2012

      Nestlé secures Pfizer unit with $11.8bn bid

      Nestlé is preparing to formally take control of the nutrition business of Pfizer by next year, after winning a hotly...

    15. April 10, 2012

      Wellcome backs free access to scientific papers

      The Wellcome Trust, one of the world’s largest funders of science research, is launching a service to make scientific papers...

    16. February 29, 2012

      Insider trading probe broadens to pharma stocks

      The US investigation into insider dealing on Wall Street has broadened to include trading of biotechnology and...

    17. January 25, 2012

      Pharma groups target specialised deals

      Roche sought to strengthen its position in personalised medicine with a $5.7bn hostile bid early on Wednesday for Illumina...

    18. December 20, 2011

      Deutsche Telekom does not leave empty-handed

      No party emerges from the collapse of AT&T’s $39bn deal to buy T-Mobile USA with much to celebrate. But Deutsche Telekom, at...

    19. August 5, 2011

      Pharma: does M&A hit R&D?

      Corporate acquisitions create excitement about cost synergies and cross-selling. Whether conjoined firms make better...

    20. June 27, 2011

      Discovery is running ahead of delivery

      When Pfizer, the US drugs company, announced the closure of its landmark research and development centre at Sandwich in the...

    21. June 15, 2011

      Fat pharm: mechanics of cost-cutting

      Losing weight is prudent, but seems a waste if a heart attack kills you anyway. A big justification for the mergers that...

    22. May 4, 2011

      Drug prescribing risks hindering TB treatment

      Wide variations in the tuberculosis drugs prescribed by private doctors in the developing world risk triggering intensified...

    23. March 8, 2011

      A sugared pill

      When Daniel Carlat, a psychiatrist in Massachusetts, was flown to New York with his wife by Wyeth, the “training” weekend he...

    24. February 16, 2011

      Conditional payment cure for pharma deals

      The head of Sanofi-Aventis predicted more use of conditional payments in future biotechnology takeovers, as he clinched the...

    25. February 6, 2011

      A bitter pill for future of British science

      The announcement last week that the US drug company Pfizer is to shut its UK research centre provoked much soul-searching,...

    26. February 2, 2011

      Pfizer chief’s remedy for long-term ills

      Pfizer appointed a new chief executive at the end of last year but the pledges and problems cited by Ian Read in his first...

    27. February 2, 2011

      Pfizer

      The more than 2,000 employees of Pfizer’s research facility in Sandwich, England, who helped develop Viagra and other...

    28. January 18, 2011

      GSK charge underlines regulatory fears

      GlaxoSmithKline’s £2.2bn legal provision unveiled this week increases its status as the pharmaceutical group with the...

    29. December 10, 2010

      Kindler to receive $16.5m from Pfizer

      Jeffrey Kindler, the outgoing chief executive of Pfizer, will receive $16.5m in a final settlement following his abrupt...

    30. December 8, 2010

      Searching for a growth remedy

      Ian Read, Pfizer chief New Pfizer chief executive Ian Read – the Briton in one of the most powerful jobs in the...

    31. December 6, 2010

      Pfizer/Merck

      It has been a tumultuous week for US big pharma. Just five days after Merck’s chief executive resigned unexpectedly, Pfizer...

    32. November 17, 2010

      European pharmaceuticals

      The European pharmaceuticals sector is in a whirl this week. It is symptomatic of an industry ever more alarmed by the...

    33. November 2, 2010

      Pfizer profits knocked by deal costs

      Quarterly profits at Pfizer slumped as the world’s largest pharmaceutical company by market value took significant...

    34. FT Alphaville

      October 13, 2010

      Pfizer snaps up King Pharma for $3.6bn

      Pfizer has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as the world’s...

    35. October 12, 2010

      Pfizer snaps up King Pharmaceuticals for $3.6bn

      Pfizer has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as the world’s...

    36. October 12, 2010

      Pfizer/King

      King Pharmaceuticals specialises in drugs that relieve pain while lessening the risk of addiction. That sounds like just...

    37. October 6, 2010

      J&J gains clout in vaccines

      Johnson & Johnson has settled on the terms of its agreed takeover of Crucell, allowing the US healthcare group to follow its...

    38. September 17, 2010

      J&J launches €1.75bn Crucell takeover

      Johnson & Johnson became the latest large healthcare group to expand into vaccines with the launch of a €1.75bn ($2.3bn)...

    Search for Wyeth Corp and